Celecoxib: A specific COX-2 inhibitor with antiinflammatory, analgesic and anticancer activities

被引：0
|
作者：
Masferrer, JL [1 ]
Leahy, K [1 ]
Kobolt, C [1 ]
Perkins, W [1 ]
Zweifel, B [1 ]
Zhang, Y [1 ]
Koki, A [1 ]
Isakson, P [1 ]
Seibert, K [1 ]
机构：
[1] GD Searle Monsanto Co, St Louis, MO 63167 USA
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SH43
引用
收藏
页码：R8 / R8
页数：1
相关论文
共 50 条
  • [21] Isolation, synthesis and characterization of impurities in Celecoxib a cox-2 inhibitor
    Satyanarayana, U
    Rao, DS
    Kumar, YR
    Babu, JM
    Kumar, PR
    Reddy, JT
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (04) : 951 - 957
  • [22] COX-2 Inhibitor, Celecoxib, May Prevent Lung Cancer
    不详
    ONCOLOGY-NEW YORK, 2011, 25 (09): : 848 - 849
  • [23] JTE-522 - Oncolytic antiinflammatory COX-2 inhibitor
    不详
    DRUGS OF THE FUTURE, 2000, 25 (06) : 638 - 638
  • [24] Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyeritis through COX-2 independent pathway
    Miyamoto, Katsuichi
    Miyake, Sachiko
    Kusunoki, Susumu
    Yamamura, Takashi
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 117 - 118
  • [25] Impact of the COX-2 selective inhibitor celecoxib on initiation and progression of atherosclerosis
    Metzner, J
    Manderscheid, C
    Popp, L
    Coste, O
    Geisslinger, G
    Niederberger, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 23 - 23
  • [26] DFT analysis and spectral characteristics of Celecoxib a potent COX-2 inhibitor
    Vijayakumar, B.
    Kannappan, V.
    Sathyanarayanamoorthi, V.
    JOURNAL OF MOLECULAR STRUCTURE, 2016, 1121 : 16 - 25
  • [27] Caution in using Celecoxib: Induction of VEGF and Angiogenesis by This COX-2 Inhibitor
    Shu, H.
    Gao, H.
    Xu, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S626 - S626
  • [28] Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC
    Srinivasu, MK
    Rao, DS
    Reddy, GO
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (3-4) : 493 - 500
  • [29] Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: What can we expect?
    Geis, GS
    JOURNAL OF RHEUMATOLOGY, 1999, 26 : 31 - 36
  • [30] Celecoxib, a COX-2 specific inhibitor in ankylosing spondylitis (AS). A 6-week efficacy study.
    Dougados, M
    Behier, JM
    Jolchine, I
    Calin, A
    van der Heijde, D
    Olivieri, I
    Zeidler, H
    Herman, H
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S103 - S103
12345